Stay updated on Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page.

Latest updates to the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page
- CheckyesterdayChange DetectedThe site footer revision label updates from v3.8.0 to v3.8.1, with no apparent changes to the study record.SummaryDifference0.0%

- Check8 days agoChange DetectedThe ClinicalTrials.gov record for the padsevonil epilepsy study is available, with information on its termination, study design, eligibility criteria, outcomes, locations, and documents.SummaryDifference100%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, which still displays a 403 error. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check43 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the previous study record content and attachments; the site’s header/footer remain, but the study details are blocked from access.SummaryDifference16%

Stay in the know with updates to Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page.